Evidence map›Paper›PMID 28724357›Full record

ArticleBMC genomics2017

Genome analysis of E. coli isolated from Crohn's disease patients.

Daria V Rakitina, Alexander I Manolov, Alexandra V Kanygina, Sofya K Garushyants, Julia P Baikova, Dmitry G Alexeev, Valentina G Ladygina, Elena S Kostryukova, Andrei K Larin, Tatiana A Semashko and 15 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Revealing AIEC Virulence Genes Behind the Mask of Antimicrobial Resistance.Cellular and molecular gastroenterology and hepatology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Role of adherent invasiveWorld journal of clinical cases · 2022
    Review
  8. Article
  9. Diversity and Adaptations ofMicroorganisms · 2021
    Article
  10. Yersiniabactin Siderophore of Crohn's Disease-Associated Adherent-InvasiveInternational journal of molecular sciences · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Frontiers in cellular and infection microbiology · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 1 country.

Daria V RakitinaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia. drakitina@list.ru.
Alexander I ManolovFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Alexandra V KanyginaMoscow Institute for Physics and Technology, Moscow, Russia.
Sofya K GarushyantsSkolkovo Institute of Science and Technology, Moscow, Russia.
Julia P BaikovaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Dmitry G AlexeevFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Valentina G LadyginaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Elena S KostryukovaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Andrei K LarinFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Tatiana A SemashkoFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Irina Y KarpovaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Vladislav V BabenkoFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Ruzilya K IsmagilovaSkolkovo Institute of Science and Technology, Moscow, Russia.
Sergei Y MalaninSkolkovo Institute of Science and Technology, Moscow, Russia.
Mikhail S GelfandSkolkovo Institute of Science and Technology, Moscow, Russia.
Elena N IlinaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Roman B GorodnichevFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Eugenia S LisitsynaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Gennady I AleshkinThe Gamaleya Research Institute for Epidemiology and Microbiology of the Russian Academy of Medical Science, Moscow, Russia.
Petr L ScherbakovCentral Scientific Institute of Gastroenterology, Moscow Clinical Research Centre, Moscow, Russia.
Igor L KhalifState Scientific Center of Coloproctology, Ministry of Health of Russian Federation, Moscow, Russia.
Marina V ShapinaState Scientific Center of Coloproctology, Ministry of Health of Russian Federation, Moscow, Russia.
Igor V MaevMoscow State University of Medicine and Dentistry named after A.I. Evdokimov, Ministry of Health of Russian Federation, Moscow, Russia.
Dmitry N AndreevMoscow State University of Medicine and Dentistry named after A.I. Evdokimov, Ministry of Health of Russian Federation, Moscow, Russia.
Vadim M GovorunFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
Federal Medical-Biological Agency · RUSkolkovo Institute of Science and Technology · RUMoscow State University of Medicine and Dentistry · RUState Scientific Center of Coloproctology · RUGamalei Institute of Epidemiology and Microbiology · RUMoscow Clinical Scientific Center · RUMoscow Institute of Physics and Technology · RUNational Research University Higher School of Economics · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEscherichia coli (E. coli) has been increasingly implicated in the pathogenesis of Crohn's disease (CD). The phylogeny of E. coli isolated from Crohn's disease patients (CDEC) was controversial, and while genotyping results suggested heterogeneity, the sequenced strains of E. coli from CD patients were closely related.

resultsWe performed the shotgun genome sequencing of 28 E. coli isolates from ten CD patients and compared genomes from these isolates with already published genomes of CD strains and other pathogenic and non-pathogenic strains. CDEC was shown to belong to A, B1, B2 and D phylogenetic groups. The plasmid and several operons from the reference CD-associated E. coli strain LF82 were demonstrated to be more often present in CDEC genomes belonging to different phylogenetic groups than in genomes of commensal strains. The operons include carbon-source induced invasion GimA island, prophage I, iron uptake operons I and II, capsular assembly pathogenetic island IV and propanediol and galactitol utilization operons.

conclusionsOur findings suggest that CDEC are phylogenetically diverse. However, some strains isolated from independent sources possess highly similar chromosome or plasmids. Though no CD-specific genes or functional domains were present in all CD-associated strains, some genes and operons are more often found in the genomes of CDEC than in commensal E. coli. They are principally linked to gut colonization and utilization of propanediol and other sugar alcohols.

Indexed as

GenomicsAdultAnti-Bacterial AgentsBacteriocinsCrohn DiseaseDrug Resistance, BacterialEscherichia coliFemaleGenetic VariationHumansMaleMiddle AgedPhylogenyYoung AdultAnti-Bacterial AgentsBacteriocinsCrohn’s diseaseE. coliGenomePropanediol

Identifiers

PMID28724357
PMCPMC5517970
OpenAlexW2739443592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.